IBT — International Biotechnology Trust Balance Sheet
0.000.00%
Last trade - 00:00
FinancialsConservativeSmall Cap
- £232.46m
- £264.94m
- £12.06m
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.886 | 0.324 | 1.56 | 0 | — |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2.59 | 0.114 | 0.898 | 13.4 | 2.93 |
Prepaid Expenses | |||||
Total Current Assets | 3.5 | 0.485 | 2.5 | 13.5 | 2.97 |
Long Term Investments | |||||
Total Assets | 241 | 303 | 348 | 327 | 305 |
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.28 | 18.8 | 24.1 | 42 | 34.6 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1.28 | 18.8 | 24.1 | 42 | 34.6 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 240 | 284 | 324 | 285 | 270 |
Total Liabilities & Shareholders' Equity | 241 | 303 | 348 | 327 | 305 |
Total Common Shares Outstanding |